Glenmede Trust’s Novavax NVAX Stock Holding History

Glenmede Trust’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,015	Closed	-$288K	–	1364
2021 Q4	$288K	Sell	2,015 -13	-0.6%	-$2.23K	﹤0.01%	1063
2021 Q3	$420K	Buy	2,028 +9	+0.4%	+$1.98K	﹤0.01%	940
2021 Q2	$428K	Sell	2,019 -1,886	-48%	-$346K	﹤0.01%	925
2021 Q1	$708K	Sell	3,905 -1,050	-21%	-$209K	﹤0.01%	746
2020 Q4	$552K	Buy	4,955 +2,277	+85%	+$242K	﹤0.01%	822
2020 Q3	$290K	Buy	2,678 +388	+17%	+$47.3K	﹤0.01%	933
2020 Q2	$190K	Buy	+2,290	New	+$87.6K	﹤0.01%	1028
2018 Q2	–	Sell	-500	Closed	-$12K	–	2200
2018 Q1	$12K	Hold	500	–	–	﹤0.01%	2128
2017 Q4	$12K	Buy	+500	New	+$12.2K	﹤0.01%	2128
2016 Q3	–	Sell	-13	Closed	-$1K	–	2650
2016 Q2	$1K	Hold	13	–	–	﹤0.01%	2475
2016 Q1	$1K	Buy	13 +3	+30%	+$322	﹤0.01%	2518
2015 Q4	$1K	Hold	10	–	–	﹤0.01%	2562
2015 Q3	$1K	Hold	10	–	–	﹤0.01%	2610
2015 Q2	$2K	Hold	10	–	–	﹤0.01%	2445
2015 Q1	$1K	Hold	10	–	–	﹤0.01%	2399
2014 Q4	$1K	Sell	10 -5	-33%	-$523	﹤0.01%	2466
2014 Q3	$1K	Hold	15	–	–	﹤0.01%	2396
2014 Q2	$1K	Hold	15	–	–	﹤0.01%	2280
2014 Q1	$1K	Sell	15 -4,082	-100%	-$456K	﹤0.01%	2289
2013 Q4	$419K	Hold	4,097	–	–	﹤0.01%	901
2013 Q3	$257K	Hold	4,097	–	–	﹤0.01%	1041
2013 Q2	$167K	Buy	+4,097	New	+$178K	﹤0.01%	1150

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Glenmede Trust's NVAX Position: Q1 2022 in Review

Glenmede Trust sold out of Novavax (NVAX) in Q1 2022, closing a stake of 2,015 shares — an estimated $288K sold.

Glenmede Trust first reported a position in NVAX in Q2 2013 and held it in 22 quarters. The position peaked at $708K in Q1 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

Glenmede Trust reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
Glenmede Trust sold 2,015 Novavax shares in Q1 2022, an estimated $288K.
Glenmede Trust first reported a position in Novavax in Q2 2013 and held it in 22 quarters.
Glenmede Trust's Novavax position peaked at $708K in Q1 2021.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Glenmede Trust's 13F filing for Q1 2022, filed 16 May 2022.